Shionogi

shionogi.com

Biotechnology

As featured in

Investing

Forbes

Claim pageClaim

Overview

News

Salaries

Products

People

Growth

Offices

Financials

Overview

Home About About Shionogi. Shaping the future of healthcare.

News

News shionogi.com 2 months ago

Shionogi Announces U.S. Availability of XOCOVA (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure Read more

Report

News investing.com 3 months ago

Shionogi Stock Price History Read more

Report

News morningstar.com 6 months ago

Shionogi Receives Contract with U.S. Government Through BARDA's Project BioShield to Enhance National Preparedness for Drug-Resistant Bacterial Threats Read more

Report

News reuters.com 2 years ago

Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial Read more

Report

Press release businesswire.com 2 years ago

Shionogi Announces New Phase 3 Data Showing Early Resolution of Many Common COVID-19 Symptoms in JAMA Network Open Read more

Report

News seekingalpha.com 3 years ago

SGIOY Shionogi & Co., Ltd. Read more

Report

News The Asahi Shimbun 4 years ago

Shionogi says COVID pill trial shows reduction in symptoms The Asahi Shimbun: Breaking News, Japan News and Analysis

Japan's Shionogi & Co. Ltd. said on Wednesday its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared with a placebo in a Phase III trial in Asia.

Report

News fiercepharma.com 4 years ago

Shionogi quests to slay antibiotic resistance with cefiderocol licensing and collaboration troika Read more

Report

News The Asahi Shimbun 4 years ago

Shionogi says continuing Vietnam COVID projects after partner scandals The Asahi Shimbun: Breaking News, Japan News and Analysis

Japan's Shionogi & Co. Ltd. said its COVID-19 projects in Vietnam are still progressing, after fraud scandals enveloped its partner there and the health ministry.